Prime Minister Opens e-Therapeutics’ Drug Discovery Centre near Oxford
News Feb 27, 2012
e-Therapeutics has announced that the UK’s Prime Minister, the Right Honourable David Cameron, MP, has opened the Company’s new drug discovery centre at Long Hanborough near Oxford.
The centre, which is located in the Prime Minister’s parliamentary constituency, will spearhead e-Therapeutics’ pioneering work in network pharmacology, a distinctive approach to the discovery of medicines with potential to produce new and improved treatments for complex diseases such as cancer.
The Prime Minister said: “e-Therapeutics is a fascinating and innovative business in my constituency. Their use of pioneering science has the potential to deliver great results and I very much hope that their treatments are successful.”
Professor Malcolm Young, founder and CEO of e-Therapeutics, said: “We are delighted to have the Prime Minister open our new drug discovery centre near Oxford, which is a world centre of excellence in the science that underpins our business.”
Severity of Autoimmune Disease Influenced by Time of DayNews
Insights into how the body clock and time of day influence immune responses are revealed today. Understanding the effect of the interplay between 24-hour day-night cycles and the immune system may help inform drug-targeting strategies to alleviate autoimmune disease.
Agent Reverses Resistance to Targeted Drug in Some LeukemiasNews
After discovering how some hematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent.READ MORE